Stroke genetics and how it Informs novel drug discovery

Julija Valančienė,Kazimieras Melaika,Aleksandra Šliachtenko,Kamilė Šiaurytė-Jurgelėnė,Aleksandra Ekkert,Dalius Jatužis,Julija ValančienėKazimieras MelaikaAleksandra ŠliachtenkoKamilė Šiaurytė-JurgelėnėAleksandra EkkertDalius Jatužisa Center of Neurology,Vilnius University,Vilnius,Lithuaniab Department of Human and Medical Genetics,Institute of Biomedical Sciences,Faculty of Medicine,Vilnius University,Vilnius,Lithuania
DOI: https://doi.org/10.1080/17460441.2024.2324916
2024-03-04
Expert Opinion on Drug Discovery
Abstract:Introduction Stroke is one of the main causes of death and disability worldwide. Nevertheless, despite the global burden of this disease, our understanding is limited and there is still a lack of highly efficient etiopathology-based treatment. It is partly due to the complexity and heterogenicity of the disease. It is estimated that around one-third of ischemic stroke is heritable, emphasizing the importance of genetic factors identification and targeting for therapeutic purposes.
pharmacology & pharmacy
What problem does this paper attempt to address?